Review Article
Published in:
Volume 2 / Year 2013 / Issue 1
Volume 2 / Year 2013 / Issue 1
Biosimilars in the European market
Author(s): Antonio Olry de Labry, PhD, Emmanuel Giménez, BSc, Leandro Lindner, BSc, Leticia García, BSc, Professor Jaime Espín, PhD, Professor Joan Rovira, PhD
Page: 30-5
Page: 30-5
Author byline as per print journal: Professor Joan Rovira, PhD; Leandro Lindner, BSc; Emmanuel Giménez, BSc; Professor Jaime Espín, PhD; Antonio Olry de Labry, PhD; Leticia García, BSc Introduction and… Read More »
Current status of biopharmaceuticals in Iran’s pharmaceutical market
Author(s): Professor Abdol Majid Cheraghali, PharmaD, PhD
Page: 26-9
Page: 26-9
Abstract: The clinical importance of biopharmaceuticals for the management of life threatening diseases is increasing but costs have become a major obstacle to the administration of these medicines, especially in… Read More »
Assessing biosimilarity and interchangeability of biosimilar products under the Biologics Price Competition and Innovation Act
Page: 20-5
Author byline as per print journal: Professor Shein-Chung Chow, PhD, Christine Ju, MSc Abstract: Biological (large molecule) drug products are made via living systems and are complex and variable in nature.… Read More »